Literature DB >> 9096423

Anal lesions: any significant prognosis in Crohn's disease?

L Siproudhis1, A Mortaji, J Y Mary, F Juguet, J F Bretagne, M Gosselin.   

Abstract

AIM: Work-up of anoperineal lesions usually includes indices of clinical activity as well as diagnostic criteria of Crohn's disease but their prognostic implication remains unclear. This prospective study was conducted in order to evaluate the overall incidence of anoperineal lesions and their relation to the natural history of underlying intestinal Crohn's disease with special reference to the steroid-dependent state of the patients. PATIENTS AND METHODS: One hundred and one patients (46 males, 55 females, aged 34 +/- 14 years; range: 15-79) were consecutively referred to our institution (May 1991 to May 1994) for intestinal symptoms related to Crohn's disease (mean duration 66 +/- 66 months). They all underwent a proctological examination regardless of perineal symptoms. The Cardiff classification was used to describe anoperineal lesions. Patients with anal lesions (64) differed from those without (37): male predisposition (53% vs. 32%, P<0.05), more frequent rectal involvement (75% vs. 24%, P<0.001) and more acute lesions observed at proctoscopic examination (42% vs. 16%, P<0.05). Age of onset, surgical past history of Crohn's disease, colonic or ileal involvement, or Harvey-Bradshaw score were not different between groups.
RESULTS: Patients with anal ulceration (43) as compared to patients having anal involvement without ulceration experienced pain more frequently (constant pain: 56 vs. 14%; defecatory pain: 35 vs. 19%) and a more severe evolution of intestinal (40 vs. 22%, P<0.05) and anal (42 vs. 12%, P<0.05) involvement. In those with an aggressive ulceration (U2, 28 patients), daily stool frequency (5.1 +/- 3 vs. 3.6 +/- 2.5, P<0.05) and clinical score (9 +/- 5 vs. 7 +/- 3) were more pronounced. Steroid therapy dependency occurred more frequently in the group with anal ulceration (35 vs. 16% and 40 vs. 17%, respectively, P<0.05). Similar associations were observed for cases of anal involvement (34 vs. 5%, P<0.01) and azathioprine was more frequently required (39 vs. 5%, P<0.01) than in those free of anal lesions. During follow-up, eight other patients required azathioprine (steroid dependence in six) and seven of them had anal lesions at referral. At the endpoint of the study, one out of two patients with anal lesions required azathioprine most often due to steroid dependency of the intestinal involvement (30/64 vs. 4/37, P<0.005).
CONCLUSION: Anal ulcerations are a reliable severity index of Crohn's disease in both short- and long-term prognosis but their link to the steroid status of the intestinal disease remains unclear.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9096423     DOI: 10.1097/00042737-199703000-00004

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  9 in total

1.  Crohn's disease: is there any link between anal and luminal phenotypes?

Authors:  Timothée Wallenhorst; Charlène Brochard; Jean-François Bretagne; Guillaume Bouguen; Laurent Siproudhis
Journal:  Int J Colorectal Dis       Date:  2015-09-26       Impact factor: 2.571

2.  Perianal Crohn's disease findings other than fistulas in a population-based cohort.

Authors:  Laurent Peyrin-Biroulet; Edward V Loftus; William J Tremaine; W Scott Harmsen; Alan R Zinsmeister; William J Sandborn
Journal:  Inflamm Bowel Dis       Date:  2011-02-23       Impact factor: 5.325

Review 3.  Anoperineal lesions in Crohn's disease: French recommendations for clinical practice.

Authors:  D Bouchard; L Abramowitz; G Bouguen; C Brochard; A Dabadie; V de Parades; M Eléouet-Kaplan; N Fathallah; J-L Faucheron; L Maggiori; Y Panis; F Pigot; P Rouméguère; A Sénéjoux; L Siproudhis; G Staumont; J-M Suduca; B Vinson-Bonnet; J-D Zeitoun
Journal:  Tech Coloproctol       Date:  2017-09-19       Impact factor: 3.781

4.  Do clinical factors help to predict disease course in inflammatory bowel disease?

Authors:  Edouard Louis; Jacques Belaiche; Catherine Reenaers
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

5.  Gut mucosal secretion of interleukin 1beta and interleukin-8 predicts relapse in clinically inactive Crohn's disease.

Authors:  I D Arnott; H E Drummond; S Ghosh
Journal:  Dig Dis Sci       Date:  2001-02       Impact factor: 3.199

6.  Frequency and significance of granulomas in a cohort of incident cases of Crohn's disease.

Authors:  D Heresbach; J L Alexandre; B Branger; J F Bretagne; E Cruchant; A Dabadie; M Dartois-Hoguin; P M Girardot; H Jouanolle; J Kerneis; J C Le Verger; V Louvain; J Politis; M Richecoeur; M Robaszkiewicz; J A Seyrig
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

7.  Elaboration and validation of Crohn's disease anoperineal lesions consensual definitions.

Authors:  Clémence Horaist; Vincent de Parades; Laurent Abramowitz; Paul Benfredj; Guillaume Bonnaud; Dominique Bouchard; Nadia Fathallah; Agnès Sénéjoux; Laurent Siproudhis; Ghislain Staumont; Manuelle Viguier; Philippe Marteau
Journal:  World J Gastroenterol       Date:  2017-08-07       Impact factor: 5.742

Review 8.  Medical and surgical management of perianal Crohn's disease.

Authors:  Samuel O Adegbola; Anthea Pisani; Kapil Sahnan; Phil Tozer; Pierre Ellul; Janindra Warusavitarne
Journal:  Ann Gastroenterol       Date:  2018-02-08

9.  Significance of Perianal Lesion in Pediatric Crohn Disease.

Authors:  Won Seok Jin; Ji Hyoung Park; Kyung In Lim; Hann Tchah; Eell Ryoo
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2018-06-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.